Covid 19 Research using Clinical Trials (Home Page)
Report for D000505: Alopecia NIH
(Synonyms: Alopecia)
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (7)
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug888 | VRC-SRSDNA015-00-VP Wiki | 1.00 |
| drug126 | Blood Test Wiki | 1.00 |
| drug611 | Physical Exam Wiki | 1.00 |
| drug889 | Vaccine Wiki | 1.00 |
| drug141 | CAG length <24 Wiki | 1.00 |
| drug142 | CAG length >=24 Wiki | 1.00 |
| drug880 | Urine Test Wiki | 1.00 |
Correlated MeSH Terms (0)
| Name (Synonyms) | Correlation |
|---|
Correlated HPO Terms (0)
| Name (Synonyms) | Correlation |
|---|
There is one clinical trial.
Clinical Trials
1 In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
The COVID-19 Androgen Sensitivity Test is a non-invasive In-Vitro Diagnostic device that utilizes Next Generation Sequencing Technology (NGS). The results of the test are used by a physician to assess the risk of developing severe symptoms following COVID-19 infection, The COVID-19 Androgen Sensitivity Test requires a health care professional to collect a DNA sample using an FDA cleared DNA sample collection kit.
NCT04368897 SARS-CoV 2 COVID COVID-19 Androgenetic Alopecia Androgen Receptor Abnormal Androgen Deficiency Diagnostic Test: CAG length <24 Diagnostic Test: CAG length >=24 MeSH:Alopecia
HPO:Alopecia Alopecia of scalp Frontal balding
Primary Outcomes
Description: Defined as 28 days minus the number of days from randomization to discharge home. If a patient has not been discharged home prior to day 28 or dies prior to day 28, hospital free days will be zero.
Measure: Hospital-free days to Day 28 [ Time Frame: 28 days] Time: 28 days
Description: Defined as discharged, hospitalization, admission to intensive care unit [ICU] and death
Measure: 1. Severity of Disease Time: Day 28
HPO Nodes
HP:0002293: Alopecia of scalp
Genes 26
CLDN1 ITGB4 PLEC KRT14 GTF2H5 MBTPS2 ERCC2 TTC7A COL17A1 MPLKIP TARS1 ECM1 RNF113A COL7A1 ERCC3 KLHL24 LAMA3 GJB2 MMP1 GTF2E2 LAMC2 LAMB3 TP63 SLC39A4 EBP COL3A1 Protein Mutations 0
SNP 1
rs2180439 HP:0001596: Alopecia
Genes 281
CLDN1 NFKB2 GTF2H5 TGM1 ANTXR1 KRAS ERCC2 KRT81 ARHGAP31 RIPK4 RECQL4 MBTPS2 LIG4 NFKB1 PORCN LMNA TP63 CSTB TARS1 NXN KDM5C AHSG MCCC2 ERCC2 FGFR1 LAMA3 KRT83 PKP1 UROS NOP10 UROD TNFRSF1B VDR TP63 NSDHL MBTPS2 GJB6 NHP2 GJB6 FZD2 MBTPS2 LIPH STAT4 WNT10A MBTPS2 TERC KRAS KDSR KRT81 GJB4 GJA1 PARN RNF113A COL7A1 EPS8L3 ERCC4 RBM28 PADI3 KRT17 USB1 CERS3 TRPV3 TINF2 SLC39A4 ALX4 FOXN1 PORCN RAG2 TERT BCS1L ACVR1 BMP2 BTD ROR2 BTD LSS ABHD5 NECTIN1 ZNF341 SMARCA2 HLCS KDM5C PNPLA6 RBPJ NPM1 CLDN1 HR AP1B1 HLCS IKBKG EXOSC2 PERP ALMS1 KRT6A PLEC KRAS KRT14 DCAF17 ZMPSTE24 TNFRSF1B TP63 IL2RG CTLA4 SLC39A4 CD28 NRAS ECM1 PNPLA1 MGP KRT74 COL7A1 BCS1L SLC29A3 MBTPS2 NRAS MMP1 LMNA GJB2 FGFR1 LAMC2 COL3A1 SLITRK1 KRT6B VDR KRT16 NIPAL4 GJB6 ITGB4 SOX18 SLC30A2 PARN PTPN22 GNA11 FAM111B RAG1 HFE DVL3 GJB2 KRT86 AIRE DSG4 LMNA SNRPE LAMB3 ITGB6 MPLKIP TERC ABCA12 CASR OFD1 ZMPSTE24 COL18A1 LMNA KLHL24 SNRPE RPL21 FOXP3 ALX4 CTC1 GJA1 WNT5A ABCD1 TRPV3 NOTCH1 KRT83 APCDD1 JUP C1R DOCK6 ANTXR1 HRAS CTLA4 DSG4 DCLRE1C RNU4ATAC HR IL7R STUB1 WNT10A RBM28 DCAF17 TTC7A LSS FLI1 RAG1 COL17A1 RTEL1 ALMS1 SPP1 HRAS ERCC3 EDAR GJB3 ALOXE3 IL7R OFD1 TP63 GJB2 HFE AIRE EBP RIPK4 DCLRE1C RIN2 IL2RA HLA-DRB1 KRT85 NECTIN4 ERCC5 LAMA3 EDNRA HFE AHSG LPAR6 PLEC PEX7 TINF2 EOGT GJA1 UBR1 LAMC2 PRKACA CHD7 ACVR1 TGM3 FOXN1 ALOX12B ALOX12B DSP HLA-DRA PIK3R1 GTF2E2 C1QA DVL1 LMNA WRAP53 ZMPSTE24 HR XPA BTK TINF2 DKC1 CD28 DKC1 ARHGAP31 RAG2 IRAK1 DDB2 ECM1 SASH1 KRT86 BTNL2 DSP ABHD5 ATR TGM1 SOX18 ADA DLL4 SOX18 TP63 LMNA MMP1 COL7A1 FTL XPC ERCC3 COL3A1 EBP HTRA1 LAMB3 HR TGM1 RMRP MBTPS2 IKBKG TERT DSP ALOXE3 NFKB2 EDARADD Protein Mutations 0
SNP 0
Primary Outcomes
Description: Defined as 28 days minus the number of days from randomization to discharge home. If a patient has not been discharged home prior to day 28 or dies prior to day 28, hospital free days will be zero.
Measure: Hospital-free days to Day 28 [ Time Frame: 28 days] Time: 28 daysDescription: Defined as discharged, hospitalization, admission to intensive care unit [ICU] and death
Measure: 1. Severity of Disease Time: Day 28